Aveanna Healthcare (NASDAQ:AVAH) Rating Increased to Overweight at Barclays

Barclays upgraded shares of Aveanna Healthcare (NASDAQ:AVAH) from an equal weight rating to an overweight rating in a report published on Tuesday morning, MarketBeat reports. The brokerage currently has $9.50 price objective on the stock, up from their previous price objective of $5.50.

Several other brokerages have also recently issued reports on AVAH. Jefferies Financial Group raised shares of Aveanna Healthcare from a “hold” rating to a “buy” rating and reduced their price target for the stock from $6.25 to $6.00 in a research report on Monday, July 21st. Raymond James Financial upgraded shares of Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 target price on the stock in a research note on Monday, August 11th. UBS Group upgraded shares of Aveanna Healthcare from a “sell” rating to a “neutral” rating and upped their target price for the stock from $6.75 to $8.00 in a research note on Tuesday. Truist Financial cut their target price on shares of Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Finally, Wall Street Zen upgraded shares of Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $7.50.

Aveanna Healthcare Stock Performance

Shares of AVAH opened at $7.27 on Tuesday. The stock has a market capitalization of $1.52 billion, a PE ratio of 90.88 and a beta of 1.95. Aveanna Healthcare has a 1 year low of $3.67 and a 1 year high of $7.61. The company’s 50-day simple moving average is $4.84 and its 200-day simple moving average is $4.90.

Insider Buying and Selling

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 750,000 shares of the stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the transaction, the insider directly owned 28,890,756 shares in the company, valued at $150,231,931.20. This represents a 2.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Patrick A. Cunningham sold 18,500 shares of the stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $4.93, for a total transaction of $91,205.00. Following the completion of the transaction, the insider owned 327,869 shares in the company, valued at $1,616,394.17. This represents a 5.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,295,145 shares of company stock valued at $11,941,141 over the last three months. 7.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Aveanna Healthcare

Hedge funds have recently added to or reduced their stakes in the stock. Banque Transatlantique SA purchased a new position in Aveanna Healthcare in the first quarter valued at approximately $25,000. BNP Paribas Financial Markets acquired a new stake in shares of Aveanna Healthcare in the fourth quarter valued at approximately $35,000. Tower Research Capital LLC TRC boosted its holdings in shares of Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock valued at $36,000 after acquiring an additional 6,854 shares during the period. Quantbot Technologies LP acquired a new stake in shares of Aveanna Healthcare in the second quarter valued at approximately $43,000. Finally, Jump Financial LLC acquired a new stake in shares of Aveanna Healthcare in the first quarter valued at approximately $59,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.